Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Fluorescence for Ureter Identification in Colorectal Surgery
NCT03177070Phase 2Completed
- Sponsor
- University of Oxford
- Start
- May 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylene blue in ureteral injury, sponsored by University of Oxford. Primary endpoint: Change in ureter identification over time using white light versus intravenous methylene blue. Started May 2016; status: completed.
02
Drugs
methylene blue
03
Conditions
ureteral injury
Beyond the preview
Go deeper on NCT03177070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177070.